Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Companys ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Companys public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR
1 set of injection 1 to 2 times a week for 1 or 2 months, or until desired results are achieved
Among MoCA-K sub-items, attention, language sub-items showed significant treatment differences in the ALC-treated group compared with placebo-treated group (Table 3)
Enoksson M, Fernandes AP, Prast S, Lillig CH, Holmgren A, Orrenius S